Rippling muscle disease with myasthenia gravis (Q88660): Difference between revisions

@@ description / pt-br / description / pt-br @@
+A doença de músculo rippling imunomediada (DMRi) pode ocorrer concomitantemente com Miastenia Gravis (MG) positiva para receptor de acetilcolina sem mutações no gene da caveolina-3 da linha germinativa. Os inibidores da acetilcolinesterase podem agravar os sintomas. MG generalizada e DMRi são tratáveis com drogas imunomoduladoras e imunossupressoras, como prednisona ou azatioprina com alívio oportuno e duradouro.
@@ description / en / description / en @@
+Immune-mediated rippling muscle disease (iRMD) may concomitantly occur with Acetylcholine receptor positive Myasthenia Gravis (MG) without germline caveolin-3 gene mutations. Acetylcholinesterase-inhibitors may aggravate the symptoms. generalised MG and iRMD are treatable by immunomodulating and immunosuppressant drugs such as prednisone or azathioprine with timely and enduring relief.
@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/327350590
@@ Property / Canonical URI: https://id.who.int/icd/entity/327350590 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:ID_327350590
@@ Property / CURIE: CID11:ID_327350590 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-ID_327350590
@@ Property / Canary Token: dki-india-ID_327350590 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank

Latest revision as of 15:00, 15 August 2026

Immune-mediated rippling muscle disease (iRMD) may concomitantly occur with Acetylcholine receptor positive Myasthenia Gravis (MG) without germline caveolin-3 gene mutations. Acetylcholinesterase-inhibitors may aggravate the symptoms. generalised MG and iRMD are treatable by immunomodulating and immunosuppressant drugs such as prednisone or azathioprine with timely and enduring relief.

Language	Label	Description	Also known as
default for all languages	ID_327350590
English	Rippling muscle disease with myasthenia gravis	Immune-mediated rippling muscle disease (iRMD) may concomitantly occur with Acetylcholine receptor positive Myasthenia Gravis (MG) without germline caveolin-3 gene mutations. Acetylcholinesterase-inhibitors may aggravate the symptoms. generalised MG and iRMD are treatable by immunomodulating and immunosuppressant drugs such as prednisone or azathioprine with timely and enduring relief.